Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
Condition(s):TuberculosisLast Updated:November 27, 2017Approved for marketing
Hide Studies Not Open or Pending
Condition(s):TuberculosisLast Updated:November 27, 2017Approved for marketing
Condition(s):Healthy VolunteerLast Updated:November 6, 2012Completed
Condition(s):Tuberculosis, Pulmonary; HIVLast Updated:January 29, 2024Recruiting
Condition(s):TuberculosisLast Updated:April 29, 2014Completed
Condition(s):TuberculosisLast Updated:April 21, 2017Completed
Condition(s):Tuberculosis; Pre-XDR-TB; Extensively Drug-Resistant Tuberculosis; Multi Drug Resistant Tuberculosis; Rifampicin Resistant TuberculosisLast Updated:October 24, 2022Active, not recruiting
Condition(s):Multi-drug Resistant TuberculosisLast Updated:December 2, 2015Withdrawn
Condition(s):Pulmonary Tuberculosis; Other Specified Pulmonary TuberculosisLast Updated:May 1, 2023Completed
Condition(s):Pulmonary TuberculosisLast Updated:December 8, 2023Recruiting
Condition(s):Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant; Tuberculosis, MDR; Tuberculosis; Drug-Resistant TuberculosisLast Updated:September 13, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.